Credit score: Novo Nordisk Novo Nordisk’s $6 billion funding at this plant in Denmark is one in every of a number of for peptide-based weight-loss medicine. Novo Nordisk is spending $6 billion in Kalundborg, Denmark, to develop the manufacturing of lively pharmaceutical components (APIs), together with peptides utilized in weight-loss and antidiabetic medicine. The Danish...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Order On: Healthy4Sure Store.

2025 © All Rights Reserved.